Wilmington, Delaware, United States, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The global market for DNA and gene cloning services was estimated to have garnered a global market valuation around US$ 2.5 billion in 2022. The market is anticipated to rise at a staggering 13.7% CAGR from 2022 to 2031 and by 2031, the market is likely to gain US$ 9.5 billion.
Gene therapy aims to treat illnesses by altering genetic information, such as turning off malfunctioning genes or substituting a disease-causing gene for a healthy copy. Successful gene therapy is being used to treat a variety of illnesses. Gene therapy can treat conditions including AIDS, cancer, diabetes, and heart disease.
Request a Report Sample to Gain Comprehensive Insights @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85195
The gene therapy market is being driven by a strong product portfolio, increased investment by key firms, increasing prevalence of target disorders, and desire in novel & creative medicines. It is projected that high product development costs and strict management standards would constrain the worldwide market. Increased investment in research and development by public and private organizations is anticipated to open up new prospects in the worldwide DNA and gene cloning services market.
Key Findings of Market Report
- The custom cloning market sector is anticipated to have substantial product growth throughout the projected period.
- The worldwide DNA and gene cloning services market has been divided into DNA sequencing, mutagenesis, genotyping, and others based on application.
- DNA variant detection is now achievable because to quick developments in sequencing and bioinformatics.
- The pharmaceutical & biotechnology businesses segment led the global market in 2021, according to end-user.
- In 2021, the market for DNA and gene cloning services was dominated by North America.
Market Trends for DNA and Gene Cloning Services
- The biological and medicinal areas are expected to undergo a significant transformation as a result of custom cloning. Two of the main advantages of employing gene custom cloning services are the analysis of the effects of mutation on a particular gene and the creation of proteins utilizing biomedical techniques.
- DNA variant detection is now achievable because to quick developments in sequencing as well as bioinformatics. These developments also pinpoint variations connected to a higher risk of illness. The additional elements enhancing genome mapping efforts internationally are technological developments, increase of partnerships and cooperation among important participants, and extension of genome mapping programs.
DNA and Gene Cloning Services Market: Regional Outlook
- In 2021, the market for DNA and gene cloning services was dominated by North America. The biomedical as well as healthcare industries' technical advancements, strategic partnerships, and acquisitions are credited with this. For example, Thermo Fisher expanded its clinical and business plasmid DNA production capabilities in December 2020. The commercialization of plasmid-based medicines and vaccines is anticipated to be accelerated by the development of a new cGMP laboratory in Carlsbad, California, in the United States. Plasmid DNA, an essential component of medications used in DNA therapies, would also be able to be produced in vast numbers at the facility. The company's continuous dedication to offering cell and gene therapy services is strengthened by this growth.
- The market for DNA and gene cloning services is anticipated to expand quickly in the Asia Pacific over the projected period due to the increased use of DNA and gene cloning in the field of life science research, as well as significant investments, financing, and regional partnerships.
Get Customization on this Report for Specific Research Solutions at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=85195
Global DNA and Gene Cloning Services Market: Key Players
The market for DNA and gene cloning services is concentrated, with only a few major firms present. The majority of businesses are making large investments in research and development, particularly to offer cutting-edge DNA and gene cloning services. Major firms to boost sales and market share are forming strategic partnerships. Mergers and acquisitions along with diversification of product portfolios are the main techniques used by major competitors to expand their footprint in the industry.
The key companies in the worldwide DNA and gene cloning services market are Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, and Twist Bioscience. Some developments by the key players in the global market for DNA and gene cloning services are:
- Pfizer and Codex DNA inked an early access partnership and license agreement in January 2021, enabling Pfizer to utilize CodexDNA's unique enzymatic synthesis of DNA technology in the investigation and creation of vaccines based on mRNA as well as biotherapies. The technology would be developed under the direction of Codex DNA.
- GenScript launched a GMP single-strand along with double-strand DNA service in May 2020 to aid in the creation of gene and cell therapies. The statement reaffirms GenScript's dedication to assisting in the development of non-viral cell therapies from the IND-enabling level to the clinical stage.
For In-Depth Competitive Analysis, Buy this Report Now@ https://www.transparencymarketresearch.com/checkout.php?rep_id=85195<ype=S
Global DNA and Gene Cloning Services Market Segmentation
- Product Type
- Gene Synthesis
- Custom Cloning
- Sub-cloning
- Others
- Application
- DNA Sequencing
- Mutagenesis
- Genotyping
- Others
- End-user
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
- Region
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
